Investing carries serious risks, including partial or total loss of capital. Please read the Key Investment Information Sheet and the Risk factors and login before investing.
Rodilo
Equity
€41,500
total amount raised in round
70%
- Eligible for a tax reduction
Our sales model is based on four complementary revenue streams
- The sale of our own condoms under our brand, through third-party distributors (never directly to the final consumer)
- The sale of pre-equipped packaging films to third-party manufacturers and brands
- The sale to manufacturers of the machines that make it possible to produce this device
- Royalties from patent and know-how licences to third-party premium brands
This model captures value both from the finished product and from intellectual property, without depending on a single channel, and without Rodilo itself bearing the manufacturing or go-to-market costs. Rodilo does not intend to sell directly to the final consumer.
Traction to date
- Several distributors already identified in Europe and Latin America, including one active negotiation
- Several industrial partners already involved in the production of condoms equipped with our device, some co-developing our first machine
- Patent already granted, with international territorial coverage and dedicated Freedom to Operate analysis
- Two independent market validations already completed: a product user test with positive results, and a third-party market study with a favourable verdict.
5-year vision
- 2027: commercial launch of the product in Germany and Latin America (March 2027); start of production of the first machine
- 2028: break-even point reached (EUR 102,000/month in revenue), first profitable financial year, positive EBITDA
- 2027–2031: targeted annual growth of +42% per year
- 2031: More than 1.6 million euros in annual revenue under our own brand name, active patent licences with various major brands in most of our regions (annual royalty income of 1.4 million euros), and machinery sold to external manufacturers.
Focus
From 2027 onwards, we will invest in:
- The industrial development of our machine, with our partners
- Strengthening the team, with priority given to an international sales/business development profile
- Commercial deployment in our priority markets (Germany and the German-speaking region, followed by Latin America) and opening the licensing model to third-party brands
Scorecard
The Scorecard is a tool designed to help investors make more informed decisions when considering investments in start-up companies. It provides an overview of a company's current situation. Developed by Spreds, it offers an objective score based on a defined set of key factors, often identified by academic research as indicators of a start-up's potential for success. The documents provided by the project owner were received by Spreds and made available to (potential) investors. The content of these documents was not analysed by Spreds nor Spreds Finance.
TAX SHELTER 45%
Investments in this company benefit from a 45% personal income tax reduction. Read more…A remaining amount of €422,500 is available for the Tax Shelter benefit.
Raise summary
| Crowd investments | €17,500 |
| Committed by others | €24,000 |
| Amount raised | €41,500 |
| Minimum round | €25,000 |
| Maximum round | €440,000 |
| Shares in the company (total round) | 12.791% |
| Pre-money valuation | €3,000,000 |
| Post-money valuation min. | €3,025,000 |
| Post-money valuation max. | €3,440,000 |